NCT01964196View on ClinicalTrials.gov

ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

September 17, 2013

Primary Completion Date

July 6, 2015

Study Completion Date

December 1, 2015

Conditions
Anemia in Chronic Kidney Disease Patients Not on Dialysis
Interventions
DRUG

ASP1517

Oral administration

DRUG

Placebo

Oral

Trial Locations (7)

Unknown

Chūbu

Hokkaido

Kansai

Kanto

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01964196 - ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis- | Biotech Hunter | Biotech Hunter